Literature DB >> 24820798

[Immediate drug hypersensitivity. Epidemiology, clinical features, triggers and management].

K Brockow1.   

Abstract

Drug hypersensitivity reactions affect more than seven percent of the population and are a concern for patients and doctors alike. In a substantial part of such reactions, IgE-mediated mechanisms have been documented. Clinical manifestations of immediate reactions, which occur directly after drug intake (mostly ≤ 1 h), are acute urticaria, angioedema, dyspnea and other symptoms of anaphylaxis in the skin, gastrointestinal tract, respiratory tract or cardiovascular system. Although normally leading to milder reactions, drugs are also the most frequent elicitors of fatal anaphylaxis. The median time interval between systemic drug application and clinical death is 5 min. The most common elicitors of immediate reactions are analgesics, antibiotics, radiocontrast media and muscle relaxants. The aim of history and experience guided skin tests ± laboratory tests is to document a sensitization, which depends on the eliciting drug and is only successful in less than half of the patients. Else a drug provocation test under controlled conditions is necessary to clarify the diagnosis and to confirm or exclude a drug hypersensitivity reaction. Therapy consists in drug avoidance or in pressing indications in tolerance induction by a "drug desensitization".

Entities:  

Mesh:

Year:  2014        PMID: 24820798     DOI: 10.1007/s00105-013-2695-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  33 in total

1.  General considerations for skin test procedures in the diagnosis of drug hypersensitivity.

Authors:  K Brockow; A Romano; M Blanca; J Ring; W Pichler; P Demoly
Journal:  Allergy       Date:  2002-01       Impact factor: 13.146

Review 2.  Lessons for management of anaphylaxis from a study of fatal reactions.

Authors:  R S Pumphrey
Journal:  Clin Exp Allergy       Date:  2000-08       Impact factor: 5.018

3.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

4.  Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test.

Authors:  Patrizia Bonadonna; Carla Lombardo; Oscar Bortolami; Andreas Bircher; Kathrin Scherer; Annick Barbaud; Giovanni Passalacqua; Mauro Pagani
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

Review 5.  Adverse side-effects to biological agents.

Authors:  W J Pichler
Journal:  Allergy       Date:  2006-08       Impact factor: 13.146

Review 6.  Allergological approach to drug hypersensitivity reactions.

Authors:  Bernhard Przybilla; Werner Aberer; Andreas J Bircher; Randolph Brehler; Knut Brockow; Heinrich Dickel; Thomas Fuchs; Michael Hertl; Maja Mockenhaupt; Oliver Pfaar; Johannes Ring; Bernhardt Sachs; Dieter Vieluf; Bettina Wedi; Margitta Worm; Torsten Zuberbier; Hans F Merk
Journal:  J Dtsch Dermatol Ges       Date:  2008-01-17       Impact factor: 5.584

Review 7.  Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs.

Authors:  M L Kowalski; R Asero; S Bavbek; M Blanca; N Blanca-Lopez; G Bochenek; K Brockow; P Campo; G Celik; J Cernadas; G Cortellini; E Gomes; E Niżankowska-Mogilnicka; A Romano; A Szczeklik; S Testi; M J Torres; S Wöhrl; J Makowska
Journal:  Allergy       Date:  2013-10-05       Impact factor: 13.146

Review 8.  Drug allergy in mast cell disease.

Authors:  Knut Brockow; Patrizia Bonadonna
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-08

9.  Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010.

Authors:  J-M Renaudin; E Beaudouin; C Ponvert; P Demoly; D-A Moneret-Vautrin
Journal:  Allergy       Date:  2013-06-06       Impact factor: 13.146

Review 10.  The epidemiology of anaphylaxis in Europe: a systematic review.

Authors:  S S Panesar; S Javad; D de Silva; B I Nwaru; L Hickstein; A Muraro; G Roberts; M Worm; M B Bilò; V Cardona; A E J Dubois; A Dunn Galvin; P Eigenmann; M Fernandez-Rivas; S Halken; G Lack; B Niggemann; A F Santos; B J Vlieg-Boerstra; Z Q Zolkipli; A Sheikh
Journal:  Allergy       Date:  2013-10-14       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.